000			02073 a2200649 4500
005			20250516004702.0
264		0	_c20110223
008			201102s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2010-06-289280 _2doi
040			_aNLM _beng _cNLM
100	1		_aItzykson, Raphael
245	0	0	_aPrognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. _h[electronic resource]
260			_bBlood _cJan 2011
300			_a403-11 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aAzacitidine _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyelodysplastic Syndromes _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aYoung Adult
700	1		_aThépot, Sylvain
700	1		_aQuesnel, Bruno
700	1		_aDreyfus, Francois
700	1		_aBeyne-Rauzy, Odile
700	1		_aTurlure, Pascal
700	1		_aVey, Norbert
700	1		_aRecher, Christian
700	1		_aDartigeas, Caroline
700	1		_aLegros, Laurence
700	1		_aDelaunay, Jacques
700	1		_aSalanoubat, Célia
700	1		_aVisanica, Sorin
700	1		_aStamatoullas, Aspasia
700	1		_aIsnard, Francoise
700	1		_aMarfaing-Koka, Anne
700	1		_ade Botton, Stephane
700	1		_aChelghoum, Youcef
700	1		_aTaksin, Anne-Laure
700	1		_aPlantier, Isabelle
700	1		_aAme, Shanti
700	1		_aBoehrer, Simone
700	1		_aGardin, Claude
700	1		_aBeach, C L
700	1		_aAdès, Lionel
700	1		_aFenaux, Pierre
773	0		_tBlood _gvol. 117 _gno. 2 _gp. 403-11
856	4	0	_uhttps://doi.org/10.1182/blood-2010-06-289280 _zAvailable from publisher's website
999			_c20244255 _d20244255